Nafcillin for Injection, USP, 2 gram per vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumbu...

FDA Recall #D-0763-2023 — Class II — May 19, 2023

Recall #D-0763-2023 Date: May 19, 2023 Classification: Class II Status: Ongoing

Product Description

Nafcillin for Injection, USP, 2 gram per vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. NDC: 25021-140-10

Reason for Recall

Lack of Assurance of Sterility

Recalling Firm

Sagent Pharmaceuticals Inc — Schaumburg, IL

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

2,249,980 vials

Distribution

Nationwide USA

Code Information

Lots: NFL101, NFL102, EXP: 1/31/2024; Lots: NFL103, NFL104, EXP: 5/31/2024; Lot: NFL201, EXP: 03/31/2025; Lot: NFL202, EXP: 5/31/2025;

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated